Leading efforts to better understand amyloidosis diseases
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.
We’re pleased to host a guest blog from Isabelle Lousada, president and CEO of the Amyloidosis Research Consortium.
Source: The Catalyst - Category: Pharmaceuticals Authors: Guest Contributor Tags: Rare Diseases & Rare Disease Day Source Type: news